Rami S. Komrokji, MD, discusses the challenges of diagnosing and treating patients with MDS and the promising treatments in phase III trials.
Experts answer questions on the optimal use of oral decitabine and FLT3 inhibitors and the current management of patients with low-risk and high-risk MDS.
Download this expert-selected slide set on optimal treatments for MDS-associated anemia.
Download this expert-selected slide set on optimal treatments for higher-risk MDS
Download this expert-selected slide set on optimal strategies for HMA treatment failure in MDS.
Download this brief summary slide set from a live CCO presentation on optimal management of patients with myelodysplastic syndromes.
Watch this on-demand Webcast capturing a live CCO Webinar to learn the latest evidence for optimizing treatment of patients with myelodysplastic syndromes (MDS).